Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Melatonergic drugs in clinical practice.
Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP. Hardeland R, et al. Among authors: poeggeler b. Arzneimittelforschung. 2008;58(1):1-10. doi: 10.1055/s-0031-1296459. Arzneimittelforschung. 2008. PMID: 18368944 Review.
Reduced oxidative damage in ALS by high-dose enteral melatonin treatment.
Weishaupt JH, Bartels C, Pölking E, Dietrich J, Rohde G, Poeggeler B, Mertens N, Sperling S, Bohn M, Hüther G, Schneider A, Bach A, Sirén AL, Hardeland R, Bähr M, Nave KA, Ehrenreich H. Weishaupt JH, et al. Among authors: poeggeler b. J Pineal Res. 2006 Nov;41(4):313-23. doi: 10.1111/j.1600-079X.2006.00377.x. J Pineal Res. 2006. PMID: 17014688 Clinical Trial.
Non-vertebrate melatonin.
Hardeland R, Poeggeler B. Hardeland R, et al. Among authors: poeggeler b. J Pineal Res. 2003 May;34(4):233-41. doi: 10.1034/j.1600-079x.2003.00040.x. J Pineal Res. 2003. PMID: 12662344 Review.
106 results